Synergistic Electrochemical Impedance Spectroscopy System

A novel system integrating electrochemical impedance spectroscopy (EIS) with artificial intelligence (AI), blockchain, IoT, and nanomaterials to predict plaque rupture, identify metabolically active atherosclerotic lesions, and enable personalized treatment of atherosclerosis.

The original patent disclosed an electrochemical impedance spectroscopy device for characterizing regions of tissue. However, it had limitations in terms of data analysis, security, and real-time feedback. The new inventive concept addresses these limitations by synergistically combining EIS with AI, blockchain, IoT, and nanomaterials to create a more powerful system for predicting plaque rupture and identifying metabolically active atherosclerotic lesions.

The new system comprises a tissue sensing device with EIS sensors, an AI module for analyzing EIS data and identifying patterns indicative of plaque rupture, a cloud-based storage system for storing and processing EIS data and AI analysis results, an IoT-enabled communication module for transmitting EIS data to a remote server, a server-side analytics platform for analyzing EIS data and providing real-time feedback to a healthcare provider, a nanomaterial-based sensor for detecting biomarkers of plaque rupture, and a microcontroller for integrating EIS data and biomarker detection results. The system can be used to predict plaque rupture, identify metabolically active atherosclerotic lesions, and enable personalized treatment of atherosclerosis.

The new claims introduce a synergistic combination of EIS with AI, blockchain, IoT, and nanomaterials, which is novel and non-obvious compared to the original patent. The integration of these distinct technologies enables a more powerful system for predicting plaque rupture and identifying metabolically active atherosclerotic lesions.

Alternative embodiments of the inventive concept could include using different types of sensors, such as optical or acoustic sensors, or integrating the system with other medical imaging modalities, such as MRI or CT scans. Variations of the system could also include using different AI algorithms or blockchain networks.

The synergistic electrochemical impedance spectroscopy system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular disease diagnosis and treatment. The system could be marketed to hospitals, clinics, and research institutions, and could potentially disrupt the current market for cardiovascular disease diagnosis and treatment.